Skip to content

CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please consider our Risk Disclosure Notice and ensure that you fully understand the risks involved. CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please consider our Risk Disclosure Notice and ensure that you fully understand the risks involved.

Australian Securities Exchange

More articles from IG: News and trade ideas Strategy and planning
Trading chart

Stock of the day: Wesfarmers

Wesfarmers' sale of Coregas for $770 million marks a strategic shift in asset management, impacting its valuation and future growth strategies on the ASX.

2024-12-20T03:19:50+0000

ASX 200

ASX 200 afternoon report: 18 December 2024

The ASX 200 sees early gains erode as markets anticipate the Federal Reserve's rate cut decision, sparking discussions on the potential commencement of the Santa Claus rally.

2024-12-18T05:55:33+0000

Graph

Stock of the day: Viva Leisure

Viva Leisure embarks on global growth by bringing Plus Fitness to the UK, showcasing strategic expansion plans amid gym industry challenges.

2024-12-18T04:18:43+0000

ASX logo

Macro Intelligence: year in review

The ASX 200 gained over 8%, driven by tech and finance, with future prospects depending on RBA cuts and geopolitical shifts.

2024-12-18T01:23:42+0000

Trading chart

Stock of the day: SPC Global Holdings

SPC Global Holdings re-enters the ASX after two decades, offering investment opportunities with its renowned food and beverage brands via a backdoor listing strategy.

2024-12-17T04:07:38+0000

laboratory

Stock of the day: Integral Diagnostics

Integral Diagnostics strengthens its market position by acquiring Capital Health, approved by ASIC. The merger presents significant investment opportunities due to undervaluation.

2024-12-11T04:42:45+0000